Evidence map›Paper›PMID 35164030›Full record

ArticleMolecules (Basel, Switzerland)2022

Yeast GH30 Xylanase from

Katarína Šuchová, Andrej Chyba, Zuzana Hegyi, Martin Rebroš, Vladimír Puchart

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Cryptococcus laurentii: a wild yeast for xylanase production from agricultural by-products.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katarína ŠuchováInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 38 Bratislava, Slovakia.ORCID 0000-0001-5529-8383
Andrej ChybaInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 38 Bratislava, Slovakia.
Zuzana HegyiInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0002-0597-0116
Martin RebrošInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Vladimír PuchartInstitute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 38 Bratislava, Slovakia.ORCID 0000-0002-6434-3462
Institute of Chemistry of the Slovak Academy of Sciences · SKSlovak University of Technology in Bratislava · SK

Funding

European Cooperation in Science and Technology CA18229Scientific Grant Agency 2/0171/22Slovak Research and Development Agency APVV-18-0254Slovak Research and Development Agency APVV-20-0591
6 · The paper itself

Abstract

Xylanases are the enzymes that catalyze the breakdown of the main hemicellulose present in plant cell walls. They have attracted attention due to their biotechnological potential for the preparation of industrially interesting products from lignocellulose. While many xylanases have been characterized from bacteria and filamentous fungi, information on yeast xylanases is scarce and no yeast xylanase belonging to glycoside hydrolase (GH) family 30 has been described so far. Here, we cloned, expressed and characterized GH30 xylanase

Indexed as

Amino Acid SequenceHydrolasesSequence Homology, Amino AcidXylosidasesYeastsglucuronoxylan xylanohydrolaseHydrolasesXylosidasesGH30-7 subfamilyglucuronoxylanaseglycoside hydrolase family 30Sugiyamaella lignohabitansxylanxylanasexylobiohydrolaseyeast

Identifiers

PMID35164030
PMCPMC8840591
OpenAlexW4210280880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.